BEAM
Price
$17.86
Change
-$0.44 (-2.40%)
Updated
Aug 7 closing price
Capitalization
1.81B
94 days until earnings call
CCCC
Price
$2.58
Change
+$0.62 (+31.63%)
Updated
Aug 7 closing price
Capitalization
139.17M
83 days until earnings call
Interact to see
Advertisement

BEAM vs CCCC

Header iconBEAM vs CCCC Comparison
Open Charts BEAM vs CCCCBanner chart's image
Beam Therapeutics
Price$17.86
Change-$0.44 (-2.40%)
Volume$1.8M
Capitalization1.81B
C4 Therapeutics
Price$2.58
Change+$0.62 (+31.63%)
Volume$9.16M
Capitalization139.17M
BEAM vs CCCC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CCCC commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and CCCC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. CCCC: $2.58)
Brand notoriety: BEAM and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. CCCC: 573%
Market capitalization -- BEAM: $1.81B vs. CCCC: $139.17M
BEAM [@Biotechnology] is valued at $1.81B. CCCC’s [@Biotechnology] market capitalization is $139.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and CCCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CCCC’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • CCCC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while CCCC (@Biotechnology) price change was +25.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CCCC is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than CCCC($139M). BEAM (-27.984) and CCCC (-28.333) have similar YTD gains . CCCC has higher annual earnings (EBITDA): -102.74M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CCCC (215M). CCCC has less debt than BEAM: CCCC (64.4M) vs BEAM (158M). BEAM has higher revenues than CCCC: BEAM (63.6M) vs CCCC (39.8M).
BEAMCCCCBEAM / CCCC
Capitalization1.81B139M1,300%
EBITDA-399.03M-102.74M388%
Gain YTD-27.984-28.33399%
P/E RatioN/AN/A-
Revenue63.6M39.8M160%
Total Cash1.22B215M567%
Total Debt158M64.4M245%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCCCC
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 21 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEGRX17.690.11
+0.63%
Janus Henderson Global Sust Eq R
PRMTX169.03N/A
N/A
T. Rowe Price Comm & Tech Investor
HGHYX39.57N/A
N/A
Hartford Healthcare Y
SUVQX12.89N/A
N/A
PGIM Quant Solutions Large-Cap Val R6
APHRX35.35-0.11
-0.31%
Artisan Global Opportunities Instl

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+31.63%
BEAM - CCCC
53%
Loosely correlated
-2.40%
SYRE - CCCC
50%
Loosely correlated
-4.51%
IDYA - CCCC
50%
Loosely correlated
-5.16%
KYMR - CCCC
50%
Loosely correlated
-4.91%
CRBU - CCCC
49%
Loosely correlated
-3.72%
More